LivaNova (NASDAQ:LIVN) Rating Increased to Strong-Buy at Zacks Research

LivaNova (NASDAQ:LIVN) was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.

Other equities analysts also recently issued reports about the company. Barclays boosted their price objective on LivaNova from $73.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Mizuho raised their target price on LivaNova from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th. KeyCorp lifted their target price on LivaNova from $83.00 to $92.00 and gave the company an “overweight” rating in a research note on Monday, June 22nd. Robert W. Baird reduced their price target on LivaNova from $78.00 to $76.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Finally, Freedom Capital raised LivaNova to a “hold” rating in a research note on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $81.38.

LivaNova Trading Down 2.0%

NASDAQ LIVN opened at $78.27 on Tuesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.11 and a current ratio of 1.33. LivaNova has a one year low of $41.01 and a one year high of $85.27. The company has a 50-day simple moving average of $78.00 and a 200-day simple moving average of $69.36. The firm has a market capitalization of $4.30 billion, a PE ratio of 40.14 and a beta of 0.86.

LivaNova (NASDAQ:LIVN) last posted its earnings results on Wednesday, May 6th. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.13. The company had revenue of $362.26 million for the quarter, compared to analysts’ expectations of $346.05 million. LivaNova had a return on equity of 16.48% and a net margin of 7.48%.The firm’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same period last year, the business posted $0.88 earnings per share. LivaNova has set its FY 2026 guidance at 4.200-4.300 EPS. On average, equities analysts forecast that LivaNova will post 3.73 earnings per share for the current year.

Insider Buying and Selling at LivaNova

In other news, Director Francesco Bianchi sold 1,800 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $75.75, for a total value of $136,350.00. Following the completion of the sale, the director owned 7,228 shares in the company, valued at $547,521. This represents a 19.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.35% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On LivaNova

Several hedge funds and other institutional investors have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of LivaNova by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,497 shares of the company’s stock worth $1,394,000 after purchasing an additional 1,360 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in LivaNova by 4.6% during the first quarter. Goldman Sachs Group Inc. now owns 814,974 shares of the company’s stock valued at $32,012,000 after purchasing an additional 36,094 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in LivaNova by 10.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 168,863 shares of the company’s stock worth $6,633,000 after buying an additional 15,405 shares in the last quarter. Intech Investment Management LLC grew its position in LivaNova by 19.6% in the first quarter. Intech Investment Management LLC now owns 43,879 shares of the company’s stock worth $1,724,000 after buying an additional 7,195 shares during the last quarter. Finally, Strs Ohio acquired a new position in LivaNova in the first quarter worth approximately $130,000. 97.64% of the stock is currently owned by institutional investors.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.